INCY Q4 Earnings Miss Estimates, Revenues Beat on Higher Product Sales

Key Takeaways INCY's Q4 adjusted EPS of $1.80 missed estimates, while revenues rose 28% year over year.Jakafi and Opzelura drove the beat, with strong demand lifting Q4 product sales above estimates.Zynyz, Niktimvo and royalties added to growth, while higher R&D and SG&A costs weighed on earnings.Incyte Corporation (INCY) reported fourth-quarter 2025 adjusted earnings of $1.80 per share, which missed the Zacks Consensus Estimate of $1.94, primarily due to higher operating expenses. The company had reported ...